other results of operations Corporate expenses Other income (expense), net Interest expense, net Corporate special income (charges) Restructuring charges and asset disposals Restructuring charges and asset disposal charges Other charges (income), net We recorded expenses of $63.0 million in 2010 compared to  $44.1 million in 2009. The increase was primarily due to increased  incentive compensation expense and consulting expense compared to  the prior year. The increase in consulting services is a result of several  new initiatives, primarily involving global procurement, aimed at  reducing the costs of goods and services purchased on a world-wide  basis. Corporate expenses are included as a component of the line item  “Selling, general and administrative expenses” on our consolidated  statements of income. Other income (expense), net is comprised primarily of LIFO inventory  adjustments and pension expense. Other expense was $18.0 million  in 2010 compared to $27.5 million in 2009. The decrease was due  primarily to income related to a decrease in our LIFO inventory  reserves. These charges were partially offset by higher pension expense  and incentive compensation. Excluding pension expense, other income  (expense), net is included as a component of the line item “Costs of  sales and services” on our consolidated statements of income. Pension  expense is included as a component of the line item “Selling, general  and administrative expenses” on our consolidated statements of income. The 2010 net interest expense increased to $39.3 million compared to  $27.0 million in 2009 primarily due to higher interest rates associated  with our senior bond offering in the fourth quarter 2009 whose proceeds  were used to pay off lower variable rate debt under out committed  credit facilities. Restructuring and other charges (income) were $151.9 million in 2010  compared to $132.8 million in 2009. Please see the table and further  discussion regarding our restructuring and other charges (income)  in Note 7 to our Consolidated Financial Statements included in  this Form 10-K. The restructuring and other charges (income) of  $151.9 million recorded in 2010 were a result of the following: • A $7.2 million charge in our Specialty Chemicals segment due to the  continued realignment of our BioPolymer alginates manufacturing  operations. The charge consisted of (i) accelerated depreciation on  fixed assets to be abandoned of $1.6 million, (ii) a reduction to  previously recorded severance reserves of $0.6 million, (iii) the accrual  of costs associated with leased properties which we have ceased using  of $5.2 million and (iv) other shut down charges of $1.0 million. • In 2009, we made the decision to close our Bayport butyllithium  facility located in Bayport, Texas, which is part of our Specialty  Chemicals segment. As the closure was finalized in 2010, we recorded  $1.1 million of income which consisted of (i) a reduction of previously  recorded retirement obligations at the site of $0.9 million and (ii) a  reduction of previously recorded severance reserves of $0.2 million. • A $13.3 million charge in our Specialty Chemicals segment due to the  realignment of our BioPolymer alginates manufacturing operations.  The charge consisted of (i) accelerated depreciation on fixed assets to  be abandoned of $8.6 million, (ii) severance and employee benefits  of $3.9 million and (iii) other shut down charges of $0.8 million. • A $1.8 million charge in our Agricultural Products segment due to  our decision to phase-out operations at our Baltimore, Maryland  agricultural chemicals facility. The charge consisted of (i) demolition  costs of $1.2 million and (ii) other shutdown costs of $0.6 million.  We ceased production at this facility in the second quarter of 2008. • A $110.4 million charge in our Industrial Chemicals segment  due to the decision to shut down our Huelva facility and exit the  phosphate business. The charge consisted of (i) severance and employee  benefits of $37.0 million, (ii) accelerated depreciation on fixed  assets to be abandoned of $69.4 million and (iii) other shut down  charges of $4.0 million. We ceased production at this facility on  December 31, 2010. • A $6.9 million charge in our Industrial Chemicals segment due  to our decision in 2009 to phase out operations of our Barcelona,  Spain facility. The charge consisted of (i) accelerated depreciation  on fixed assets to be abandoned of $10.1 million and (ii) other costs  of $1.0 million, mainly related to spare part write-offs and contract  termination expenses, partially offset by (iii) recoveries associated  with the phase out of $4.0 million, and (iv) a reduction to previously  recorded severance reserves of $0.2 million. The recoveries represented  the sale of the land lease rights associated with a portion of this facility. • In 2009, we made the decision to shut down our manufacturing  operations at our Peroxygens facility in Santa Clara, Mexico, which is  part of our Industrial Chemicals segment. During 2010, we recorded  $1.0 million of income which related to the reversal of a previously  recorded loss contingency. • Severance costs due to other workforce restructurings of $5.5 million  primarily related to our Industrial Chemicals segment. • A $0.7 million gain, primarily related to foreign currency translation  adjustment as a result of the liquidation of a legal entity that owned  a co-generation facility at Foret. • Corporate net charges of $14.2 million relating to environmental  remediation at operating sites. • A $5.7 million charge related to our Agricultural Products segment  acquiring certain rights relating to a herbicide compound still under  development. • $1.5 million of net charges primarily related to a legal settlement  associated with the U.S. hydrogen peroxide matter in our Industrial  Chemicals segment. • $0.5 million of charges in our Agricultural Products segment related  to a collaboration and license agreement with a third-party company. • $2.8 million of charges, primarily relating to the accrual of interest  associated with a European Commission fine currently being appealed. The restructuring and other charges (income) of $132.8 million recorded  in 2009 were a result of the following: 23 FMC Corporation    2010 Form 10K Part II  iteM 7 Management’s Discussion and analysis of Financial Condition and results of operations